BioCryst Pharmaceuticals, Inc. ( BCRX) - Stock Earnings
BCRX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 2, 2026, midnight | — / — | — | — / — | — |
BCRX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 245.8 million USD | 406.6 million USD |
| 2026Q1 | -721.8 million USD | 156.4 million USD |
| 2026Q2 | 78.4 million USD | 218.3 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
BCRX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -226.5 million USD | 331.4 million USD |
| 2024 | -88.9 million USD | 450.7 million USD |
| 2025 | 263.9 million USD | 874.8 million USD |
| 2026 Est. | — | — |
BCRX
Price: $7.88
52 week price:
Earnings Per Share: -1.47 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.7 million
Ebitda: -12.8 millionMarket Capitalization: 2.0 billion